Richard Koehn
Gründer bei SentrX Animal Care, Inc.
Profil
Richard K.
Koehn was the founder of Carbylan Therapeutics, Inc. (founded in 2005) and SentrX Animal Care, Inc. (founded in 2006) where he holds the titles of Director and Chairman respectively.
He also held the position of Chief Executive Officer at Salus Therapeutics, Inc. and Vice President-Research at the University of Utah from 1992 to 2000.
Aktive Positionen von Richard Koehn
| Unternehmen | Position | Beginn |
|---|---|---|
SentrX Animal Care, Inc.
 SentrX Animal Care, Inc. Pharmaceuticals: MajorHealth Technology SentrX Animal Care, Inc. provides veterinary care services for animals. Its products include gels, film and field treatment kits, film-on-gauzes, adhesion prevention films, spray bottles, and corneal repair gel drops. The company’s products are used for horses, cats and dogs. The company was founded by Richard K. Koehn and Glenn D. Prestwich in 2006 and is headquartered in Salt Lake City, UT. | Gründer | 15.02.2010 |
Ehemalige bekannte Positionen von Richard Koehn
| Unternehmen | Position | Ende |
|---|---|---|
| University of Utah | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2000 |
Carbylan Therapeutics, Inc.
 Carbylan Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Carbylan Therapeutics, Inc. engages in the development and market of medical devices and drug combination products to treat the pain associated with osteoarthritis. It offers Hydros Joint Therapy and Hydros-TA Joint Therapy, viscoelastic hyaluronan-based products designed to provide long term relief of the pain associated with osteoarthritis using a single intra-articular injection. The company was founded by Richard R. Orlandi, Albert Park, Glenn D. Prestwich and Richard K. Koehn in March 2004 and is headquartered in Palo Alto, CA. | Gründer | - |
Salus Therapeutics, Inc.
 Salus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Salus Therapeutics, Inc. discovers and develops RNA pharmaceutical products. It engages in the identification of drugs based on deoxyribonucleic acid (DNA) or ribonucleic acid (RNA). Its drugs include antisense, small interfering RNAs, and delivery systems for DNA/RNA-based drugs. The company was founded by Dinesh C. Patel and is headquartered in Salt Lake City, UT. | Vorstandsvorsitzender | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Carbylan Therapeutics, Inc.
Carbylan Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Carbylan Therapeutics, Inc. engages in the development and market of medical devices and drug combination products to treat the pain associated with osteoarthritis. It offers Hydros Joint Therapy and Hydros-TA Joint Therapy, viscoelastic hyaluronan-based products designed to provide long term relief of the pain associated with osteoarthritis using a single intra-articular injection. The company was founded by Richard R. Orlandi, Albert Park, Glenn D. Prestwich and Richard K. Koehn in March 2004 and is headquartered in Palo Alto, CA. | Health Technology |
SentrX Animal Care, Inc.
SentrX Animal Care, Inc. Pharmaceuticals: MajorHealth Technology SentrX Animal Care, Inc. provides veterinary care services for animals. Its products include gels, film and field treatment kits, film-on-gauzes, adhesion prevention films, spray bottles, and corneal repair gel drops. The company’s products are used for horses, cats and dogs. The company was founded by Richard K. Koehn and Glenn D. Prestwich in 2006 and is headquartered in Salt Lake City, UT. | Health Technology |
Salus Therapeutics, Inc.
Salus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Salus Therapeutics, Inc. discovers and develops RNA pharmaceutical products. It engages in the identification of drugs based on deoxyribonucleic acid (DNA) or ribonucleic acid (RNA). Its drugs include antisense, small interfering RNAs, and delivery systems for DNA/RNA-based drugs. The company was founded by Dinesh C. Patel and is headquartered in Salt Lake City, UT. | Health Technology |
